dc.contributor.author | Yenerel, Mustafa Nuri | |
dc.contributor.author | Byrd, John C. | |
dc.contributor.author | Hillmen, Peter | |
dc.contributor.author | Ghia, Paolo | |
dc.contributor.author | Kater, Arnon P. | |
dc.contributor.author | Chanan-Khan, Asher Alban Akmal | |
dc.contributor.author | Furman, Richard R. | |
dc.contributor.author | O'Brien, Susan M. | |
dc.contributor.author | Illes, Arpad | |
dc.contributor.author | Kay, Neil E. | |
dc.contributor.author | Marco, Jose Antonio Garcia | |
dc.contributor.author | Mato, Anthony R. | |
dc.contributor.author | Francis, John | |
dc.contributor.author | Lepretre, Seymour Stephane | |
dc.contributor.author | Stilgenbauer, Stephan | |
dc.contributor.author | Robak, Tadeusz | |
dc.contributor.author | Patel, Priti | |
dc.contributor.author | Higgins, Kara | |
dc.contributor.author | Sohoni, Sophia | |
dc.contributor.author | Jurczak, Wojciech | |
dc.date.accessioned | 2022-07-04T16:24:37Z | |
dc.date.available | 2022-07-04T16:24:37Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Byrd J. C. , Hillmen P., Ghia P., Kater A. P. , Chanan-Khan A. A. A. , Furman R. R. , O'Brien S. M. , Yenerel M. N. , Illes A., Kay N. E. , et al., "First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.", JOURNAL OF CLINICAL ONCOLOGY, cilt.39, sa.15, 2021 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.other | av_e3932085-ca7c-4a2e-a49e-c0486e0e9fbf | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/185090 | |
dc.identifier.uri | https://doi.org/10.1200/jco.2021.39.15_suppl.7500 | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | Oncology | |
dc.subject | Health Sciences | |
dc.title | First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia. | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF CLINICAL ONCOLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 39 | |
dc.identifier.issue | 15 | |
dc.contributor.firstauthorID | 3398795 | |